SLN vs NBN Comparison

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The bank conducts its loan-related activities through two primary channels: the National Lending Division and the Small Business Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans; consumer loans; and small business administration loans, among others. Additionally, the bank provides telephone banking, online banking, mobile banking, and remote deposit capture services, and other banking products and services. The majority of its revenue is derived in the form of interest and dividends.